Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Johnson & Johnson diskutieren

Johnson & Johnson

WKN: 853260 / Symbol: JNJ / Name: Johnson & Johnson / Aktie / Pharmazeutika / Large Cap /

138,20 €
-1,10 %

Einschätzung Buy
Rendite (%) 3,42 %
Kursziel 197,11
Veränderung
Endet am 17.11.24

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,02 %
Kursziel 165,58
Veränderung
Endet am 01.12.24

Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $180.00 price target on the stock, up previously from $167.00.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,08 %
Kursziel 163,56
Veränderung
Endet am 01.12.24

Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $178.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,67 %
Kursziel 160,34
Veränderung
Endet am 03.01.25

Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at Raymond James from $172.00 to $175.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,74 %
Kursziel 196,36
Veränderung
Endet am 09.01.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,61 %
Kursziel 198,45
Veränderung
Endet am 23.01.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,56 %
Kursziel 166,03
Veränderung
Endet am 24.01.25

Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,50 %
Kursziel 200,04
Veränderung
Endet am 06.02.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,45 %
Kursziel 198,81
Veränderung
Endet am 20.02.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,93 %
Kursziel 167,03
Veränderung
Endet am 28.02.25

Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,19 %
Kursziel 197,69
Veränderung
Endet am 18.03.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,16 %
Kursziel 202,12
Veränderung
Endet am 15.04.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat